ETCABio - Evaluation of Skin Tests in Biotherapy Allergies
This study, called ETCABio, is about making sure advanced cancer treatments, known as biotherapies, are as safe as possible for your skin. We're testing how your skin reacts to different strengths of these medicines. The main goal is to find the highest dose of each biotherapy that doesn't cause a skin reaction in at least 9 out of 10 people when applied to the skin. This helps us understand what concentrations are safe to use for skin testing, preventing irritation. We also check for any delayed skin reactions or reactions throughout the body after the treatment. Understanding these reactions helps doctors use these important medicines more safely.
At a glance
What is this study about?
This study, called ETCABio, is all about understanding how your skin reacts to certain advanced cancer medicines. These medicines, called 'biotherapies' (you might also hear them called immunotherapy), are powerful treatments for various cancers. While they are very important, sometimes people can have skin reactions to them.
The main aim of this study is to find the highest amount (or 'concentration') of each biotherapy that can be safely used on your skin during special allergy tests. Think of it like finding the right strength of a new cream – you want it to work without causing irritation. For this study, if 9 out of 10 people don't have a skin reaction to a certain concentration, we consider that a safe starting point for allergy testing.
We're also interested in reactions that might show up a bit later, not just right away. Sometimes a skin reaction might appear 48 hours or even a week after a test. We'll even check if there are any body-wide reactions after you've had the biotherapy. By carefully studying these skin responses, we can help doctors give these vital cancer treatments in the safest way possible, reducing the chance of unwanted skin problems for patients like you.
Key takeaways
- The study helps make immunotherapy cancer treatments safer.
- It checks how your skin reacts to specific cancer drugs.
- The goal is to find the safest dose for skin allergy tests.
- It applies to many types of cancer, including melanoma and lymphoma.
- You won't receive new medicine; it's about testing current treatments.
- Participation involves skin tests and checking for delayed reactions.
Who may be eligible?
This study is open to both men and women aged 18 years and older. There is no upper age limit, so adults of all ages can potentially take part.
Participants in this study will be people who are already receiving, or are about to receive, one of the biotherapy medications being studied for their cancer. These cancers include various types such as colorectal cancer, lymphoma, leukemia, melanoma, and lung cancer, among others.
Essentially, if you are an adult receiving a specific set of advanced cancer treatments and your doctor believes you might benefit from having your skin's reaction to these treatments assessed, you could be eligible.
- Are you 18 years old or older?
- Are you currently receiving or about to start one of the listed biotherapy cancer treatments?
- Do you have a type of cancer mentioned in the study (e.g., colorectal cancer, lymphoma, melanoma)?
- Are you comfortable with allergy skin tests?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you take part in this study, you won't be starting a new treatment; instead, we'll be carefully checking your skin's reaction to the biotherapy you are already receiving or are scheduled to receive. This will involve 'skin testing,' where very tiny amounts of the biotherapy will be applied to your skin. We'll be looking for any redness, itchiness, or swelling at these test sites.
After the initial skin test, you might be contacted by phone to check if you have any delayed skin reactions that appear 48 hours or a week later. If a reaction is suspected, you might be asked to come for a consultation with an allergy specialist, or a video call might be arranged, where a photo of the reaction can be taken. The total duration of your participation would depend on how long these checks for delayed reactions are needed, but it's focused on understanding your immediate and short-term skin responses to the medication.
Potential risks and benefits
Locations (1)
- —France
Common questions
What kind of cancer treatments are being studied?
We are studying advanced cancer treatments called biotherapies, also known as immunotherapies, for many different types of cancer, like colorectal cancer, lymphoma, and melanoma.
Why is this study important?
This study helps doctors understand how your skin reacts to these powerful medicines, so they can be given in the safest way possible, reducing unwanted skin problems.
Will I get a new medicine in this study?
No, you won't get a new medicine. This study simply checks how your skin reacts to the biotherapy you are already taking or are about to start for your cancer.
What does 'skin testing' involve?
Skin testing means applying very small amounts of the medicine to your skin to see if it causes any redness, itching, or swelling.
What if I have a reaction after the test?
The study team will check for any delayed reactions. If one occurs, you might have a follow-up appointment or a video call to assess it.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.